Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

NACompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

January 4, 2016

Primary Completion Date

July 21, 2020

Study Completion Date

August 16, 2021

Conditions
Spinal Metastases
Interventions
RADIATION

20 Gy in 5 fractions

RADIATION

Conventional SBRT: 24 Gy in 2 fractions

Trial Locations (22)

1023

Auckland City Hospital, Grafton

2170

Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool

3002

Peter McCallum Cancer Institute, Melbourne

3021

Peter Mac - Sunshine Hospital, St Albans

4029

Royal Brisbane and Womens Hospital, Herston

4102

Princess Alexandra Hospital, Brisbane

5000

Royal Adelaide Hospital, Adelaide

ACT 2605

Canberra Hospital, Garran

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V2M 7E9

BCCA - Centre for the North, Prince George

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

V8R 6V5

BCCA - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

N6A 5W9

London Regional Cancer Program, London

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M4N 3M5

Odette Cancer Centre, Toronto

M5G 2M9

University Health Network, Toronto

H2X 3E4

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Trans Tasman Radiation Oncology Group

OTHER

lead

Canadian Cancer Trials Group

NETWORK

NCT02512965 - Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases | Biotech Hunter | Biotech Hunter